Bridgeway Capital Management’s Avid Bioservices, Inc. Common Stock CDMO Stock Holding History

Bridgeway Capital Management’s Portfolio CDMO Stock Details CDMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,900	Closed	-$285K	–	1473
2022 Q3	$285K	Hold	14,900	–	–	0.01%	1059
2022 Q2	$227K	Hold	14,900	–	–	0.01%	1063
2022 Q1	$304K	Hold	14,900	–	–	0.01%	1076
2021 Q4	$435K	Hold	14,900	–	–	0.01%	1022
2021 Q3	$321K	Hold	14,900	–	–	0.01%	1141
2021 Q2	$382K	Hold	14,900	–	–	0.01%	1144
2021 Q1	$272K	Sell	14,900 -19,000	-56%	-$316K	0.01%	1247
2020 Q4	$391K	Buy	33,900 +19,000	+128%	+$174K	0.01%	1036
2020 Q3	$114K	Buy	+14,900	New	+$113K	﹤0.01%	1250

Other funds holding CDMO

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return

AltraVue Capital Bellevue, Washington $1.16B AUM 46.45% 1-Year Est. Return

Jennison Associates New York $145B AUM 34.61% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

SCM

Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return

Bridgeway Capital Management's CDMO Position: Q4 2022 in Review

Bridgeway Capital Management sold out of Avid Bioservices, Inc. Common Stock (CDMO) in Q4 2022, closing a stake of 14,900 shares — an estimated $285K sold.

Bridgeway Capital Management first reported a position in CDMO in Q3 2020 and held it in 9 quarters. The position peaked at $435K in Q4 2021. 168 funds tracked by Wall St. Rank hold CDMO as of Q4 2022.

Bridgeway Capital Management reported no remaining Avid Bioservices, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Bridgeway Capital Management sold 14,900 Avid Bioservices, Inc. Common Stock shares in Q4 2022, an estimated $285K.
Bridgeway Capital Management first reported a position in Avid Bioservices, Inc. Common Stock in Q3 2020 and held it in 9 quarters.
Bridgeway Capital Management's Avid Bioservices, Inc. Common Stock position peaked at $435K in Q4 2021.
168 funds tracked by Wall St. Rank held Avid Bioservices, Inc. Common Stock as of Q4 2022.

Based on Bridgeway Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.